Mobile health solutions: An opportunity for rehabilitation in low- and middle income countries?
Frontiers in Public Health · 24.01.2023 · 10
DOI: 10.3389/fpubh.2022.1072322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 24.01.2023. Verfasst von Bruno Bonnechère und 7 weiteren Autor:innen. Beteiligte Einrichtung: REVAL Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University (UHasselt), Hasselt, Belgium. Hauptthemen laut MEDLINE: Developing Countries, Telemedicine. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mobile health (mHealth) development has advanced rapidly, indicating promise as an effective patient intervention. mHealth has many potential benefits that could help the treatment of patients, and the development of rehabilitation in low- and middle-income countries (LMICs). mHealth is a low-cost option that does not need rapid access to healthcare clinics or employees. It increases the feasibility and rationality of clinical treatment expectations in comparison to the conventional clinical model of management by promoting patient adherence to the treatment plan. mHealth can also serve as a basis for formulating treatment plans and partially compensate for the shortcomings of the traditional model. In addition, mHealth can help achieve universal rehabilitation service coverage by overcoming geographical barriers, thereby increasing the number of ways patients can benefit from the rehabilitation service, and by providing rehabilitation to individuals in remote areas and communities with insufficient healthcare services. However, despite these positive potential aspects, there is currently only a very limited number of studies performed in LMICs using mHealth. In this study, we first reviewed the current evidence supporting the use of mHealth in rehabilitation to identify the countries where studies have been carried out. Then, we identify the current limitations of the implementation of such mHealth solutions and propose a 10-point action plan, focusing on the macro (e.g., policymakers), meso (e.g., technology and healthcare institutions), and micro (e.g., patients and relatives) levels to ease the use, validation, and implementation in LMICs and thus participate in the development and recognition of public health and rehabilitation in these countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- REVAL Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University (UHasselt), Hasselt, Belgium.
- Technology-Supported and Data-Driven Rehabilitation, Data Science Institute, UHasselt, Hasselt, Belgium.
- ENATSE, National School of Public Health and Epidemiology, University of Parakou, Parakou, Benin.
- INSP, Institut National de la Santé Publique, Bujumbura, Burundi.
- CKAO-AMAHORO, Cabinet de Kinésithérapie et d'Appareillage Orthopédique, Bujumbura, Burundi.
- University of Lubumbashi, Lubumbashi, Democratic Republic of Congo.
Zitieren
APA
Bonnechère, B., Kossi, O., Mapinduzi, J., Panda, J., Rintala, A., Guidetti, S., Spooren, A., & Feys, P. (2023). Mobile health solutions: An opportunity for rehabilitation in low- and middle income countries?. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.1072322
Vancouver
Bonnechère B, Kossi O, Mapinduzi J, Panda J, Rintala A, Guidetti S, et al. Mobile health solutions: An opportunity for rehabilitation in low- and middle income countries?. Frontiers in Public Health. 2023;10. doi:10.3389/fpubh.2022.1072322
BibTeX
@article{Bonnechre2023,
author = {Bonnechère, Bruno and Kossi, Oyene and Mapinduzi, Jean and Panda, Jules and Rintala, Aki and Guidetti, Susanne and Spooren, Annemie and Feys, Peter},
title = {Mobile health solutions: An opportunity for rehabilitation in low- and middle income countries?},
journal = {Frontiers in Public Health},
year = {2023},
volume = {10},
doi = {10.3389/fpubh.2022.1072322}
}
EUVIMED